1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Weight Gain in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dombrowsky, H; Frerichs, I; Lautenschläger, I; Lindner, B; Schultz, H; Uhlig, S; Weiler, N; Zehethofer, N | 1 |
At Muhammed, R; El-Medany, A; El-Medany, G; El-Rakhawy, FI; Hagar, HH; Moursi, M | 1 |
Palmer, C; Roberts, RL; Viswanath, M | 1 |
3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Weight Gain
Article | Year |
---|---|
Ingestion of (n-3) fatty acids augments basal and platelet activating factor-induced permeability to dextran in the rat mesenteric vascular bed.
Topics: Animals; Capillary Permeability; Dextrans; Dietary Fats; Fatty Acids, Omega-3; Female; Phospholipids; Platelet Activating Factor; Rats; Rats, Wistar; Splanchnic Circulation; Weight Gain | 2011 |
Attenuation of bleomycin-induced lung fibrosis in rats by mesna.
Topics: Animals; Bleomycin; Drug Administration Schedule; Drug Screening Assays, Antitumor; Glutathione; Hydroxyproline; Injections, Intraperitoneal; Lung; Male; Mesna; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Peroxidase; Platelet Activating Factor; Pulmonary Fibrosis; Rats; Rats, Wistar; Time Factors; Tumor Necrosis Factor-alpha; Weight Gain; Weight Loss | 2005 |
Reduction of hypoxic-ischemic brain swelling in the neonatal rat with PAF antagonist WEB 2170: lack of long-term protection.
Topics: Animals; Animals, Newborn; Atrophy; Azepines; Brain; Brain Edema; Female; Hypoxia-Ischemia, Brain; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Triazoles; Weight Gain | 2000 |